nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—ABCB1—peripheral nervous system neoplasm	0.244	1	CbGaD
Nelfinavir—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0534	0.0916	CbGbCtD
Nelfinavir—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.037	0.0635	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0366	0.0629	CbGbCtD
Nelfinavir—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0366	0.0629	CbGbCtD
Nelfinavir—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0349	0.0599	CbGbCtD
Nelfinavir—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0275	0.0472	CbGbCtD
Nelfinavir—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0228	0.0391	CbGbCtD
Nelfinavir—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.022	0.0378	CbGbCtD
Nelfinavir—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0212	0.0365	CbGbCtD
Nelfinavir—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0209	0.0358	CbGbCtD
Nelfinavir—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0192	0.033	CbGbCtD
Nelfinavir—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0192	0.033	CbGbCtD
Nelfinavir—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0184	0.0316	CbGbCtD
Nelfinavir—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0176	0.0302	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0168	0.0289	CbGbCtD
Nelfinavir—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0168	0.0289	CbGbCtD
Nelfinavir—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0149	0.0257	CbGbCtD
Nelfinavir—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0142	0.0244	CbGbCtD
Nelfinavir—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0133	0.0229	CbGbCtD
Nelfinavir—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0126	0.0217	CbGbCtD
Nelfinavir—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0116	0.0199	CbGbCtD
Nelfinavir—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0115	0.0198	CbGbCtD
Nelfinavir—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0107	0.0184	CbGbCtD
Nelfinavir—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.01	0.0172	CbGbCtD
Nelfinavir—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00861	0.0148	CbGbCtD
Nelfinavir—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00821	0.0141	CbGbCtD
Nelfinavir—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00789	0.0136	CbGbCtD
Nelfinavir—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00766	0.0132	CbGbCtD
Nelfinavir—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00753	0.0129	CbGbCtD
Nelfinavir—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00513	0.00881	CbGbCtD
Nelfinavir—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00492	0.00845	CbGbCtD
Nelfinavir—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00484	0.0083	CbGbCtD
Nelfinavir—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00451	0.00774	CbGbCtD
Nelfinavir—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00308	0.00528	CbGbCtD
Nelfinavir—Indinavir—ABCB1—peripheral nervous system neoplasm	0.000552	0.572	CrCbGaD
Nelfinavir—Saquinavir—ABCB1—peripheral nervous system neoplasm	0.000412	0.427	CrCbGaD
Nelfinavir—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000856	CcSEcCtD
Nelfinavir—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000147	0.000852	CcSEcCtD
Nelfinavir—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000147	0.000852	CcSEcCtD
Nelfinavir—Rash—Topotecan—peripheral nervous system neoplasm	0.000147	0.000852	CcSEcCtD
Nelfinavir—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000147	0.000851	CcSEcCtD
Nelfinavir—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000147	0.00085	CcSEcCtD
Nelfinavir—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000146	0.000847	CcSEcCtD
Nelfinavir—Headache—Topotecan—peripheral nervous system neoplasm	0.000146	0.000846	CcSEcCtD
Nelfinavir—Rash—Tretinoin—peripheral nervous system neoplasm	0.000146	0.000845	CcSEcCtD
Nelfinavir—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000146	0.000845	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000146	0.000845	CcSEcCtD
Nelfinavir—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000146	0.000844	CcSEcCtD
Nelfinavir—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000146	0.000844	CcSEcCtD
Nelfinavir—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000145	0.000841	CcSEcCtD
Nelfinavir—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000145	0.000841	CcSEcCtD
Nelfinavir—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000841	CcSEcCtD
Nelfinavir—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000145	0.00084	CcSEcCtD
Nelfinavir—Headache—Tretinoin—peripheral nervous system neoplasm	0.000145	0.000839	CcSEcCtD
Nelfinavir—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000145	0.000839	CcSEcCtD
Nelfinavir—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000144	0.000837	CcSEcCtD
Nelfinavir—Pain—Vincristine—peripheral nervous system neoplasm	0.000144	0.000837	CcSEcCtD
Nelfinavir—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000836	CcSEcCtD
Nelfinavir—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000144	0.000836	CcSEcCtD
Nelfinavir—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000834	CcSEcCtD
Nelfinavir—Rash—Melphalan—peripheral nervous system neoplasm	0.000144	0.000834	CcSEcCtD
Nelfinavir—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000144	0.000833	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000143	0.00083	CcSEcCtD
Nelfinavir—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000826	CcSEcCtD
Nelfinavir—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000142	0.000825	CcSEcCtD
Nelfinavir—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000823	CcSEcCtD
Nelfinavir—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000823	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000142	0.000821	CcSEcCtD
Nelfinavir—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000141	0.000817	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000814	CcSEcCtD
Nelfinavir—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000139	0.000807	CcSEcCtD
Nelfinavir—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000139	0.000807	CcSEcCtD
Nelfinavir—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000138	0.000803	CcSEcCtD
Nelfinavir—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000138	0.000803	CcSEcCtD
Nelfinavir—Nausea—Topotecan—peripheral nervous system neoplasm	0.000138	0.000802	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000138	0.0008	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000797	CcSEcCtD
Nelfinavir—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000797	CcSEcCtD
Nelfinavir—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000137	0.000796	CcSEcCtD
Nelfinavir—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000137	0.000796	CcSEcCtD
Nelfinavir—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000792	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000136	0.000788	CcSEcCtD
Nelfinavir—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000786	CcSEcCtD
Nelfinavir—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000136	0.000786	CcSEcCtD
Nelfinavir—Nausea—Melphalan—peripheral nervous system neoplasm	0.000136	0.000785	CcSEcCtD
Nelfinavir—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000778	CcSEcCtD
Nelfinavir—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000134	0.000777	CcSEcCtD
Nelfinavir—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000134	0.000776	CcSEcCtD
Nelfinavir—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000133	0.000773	CcSEcCtD
Nelfinavir—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000133	0.000773	CcSEcCtD
Nelfinavir—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000772	CcSEcCtD
Nelfinavir—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000133	0.000771	CcSEcCtD
Nelfinavir—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000133	0.00077	CcSEcCtD
Nelfinavir—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000132	0.000766	CcSEcCtD
Nelfinavir—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000766	CcSEcCtD
Nelfinavir—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000764	CcSEcCtD
Nelfinavir—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00013	0.000755	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000753	CcSEcCtD
Nelfinavir—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00013	0.000752	CcSEcCtD
Nelfinavir—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000129	0.000749	CcSEcCtD
Nelfinavir—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000129	0.000748	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000129	0.000747	CcSEcCtD
Nelfinavir—Pain—Cisplatin—peripheral nervous system neoplasm	0.000128	0.00074	CcSEcCtD
Nelfinavir—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000738	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000738	CcSEcCtD
Nelfinavir—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000731	CcSEcCtD
Nelfinavir—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000126	0.000728	CcSEcCtD
Nelfinavir—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000728	CcSEcCtD
Nelfinavir—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000124	0.000721	CcSEcCtD
Nelfinavir—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000124	0.000718	CcSEcCtD
Nelfinavir—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000123	0.000713	CcSEcCtD
Nelfinavir—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000123	0.000712	CcSEcCtD
Nelfinavir—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000709	CcSEcCtD
Nelfinavir—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000122	0.000707	CcSEcCtD
Nelfinavir—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000705	CcSEcCtD
Nelfinavir—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000122	0.000705	CcSEcCtD
Nelfinavir—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000121	0.000702	CcSEcCtD
Nelfinavir—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000701	CcSEcCtD
Nelfinavir—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00012	0.000696	CcSEcCtD
Nelfinavir—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00012	0.000695	CcSEcCtD
Nelfinavir—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000119	0.00069	CcSEcCtD
Nelfinavir—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000119	0.000689	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000118	0.000684	CcSEcCtD
Nelfinavir—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000118	0.000684	CcSEcCtD
Nelfinavir—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000679	CcSEcCtD
Nelfinavir—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000679	CcSEcCtD
Nelfinavir—Pain—Etoposide—peripheral nervous system neoplasm	0.000117	0.000678	CcSEcCtD
Nelfinavir—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000676	CcSEcCtD
Nelfinavir—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000116	0.000671	CcSEcCtD
Nelfinavir—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000115	0.000669	CcSEcCtD
Nelfinavir—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000668	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000659	CcSEcCtD
Nelfinavir—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000657	CcSEcCtD
Nelfinavir—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000653	CcSEcCtD
Nelfinavir—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000113	0.000653	CcSEcCtD
Nelfinavir—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000652	CcSEcCtD
Nelfinavir—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000112	0.00065	CcSEcCtD
Nelfinavir—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000648	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000112	0.000648	CcSEcCtD
Nelfinavir—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000112	0.000647	CcSEcCtD
Nelfinavir—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000111	0.000646	CcSEcCtD
Nelfinavir—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00011	0.00064	CcSEcCtD
Nelfinavir—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00011	0.00064	CcSEcCtD
Nelfinavir—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00011	0.000637	CcSEcCtD
Nelfinavir—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00011	0.000636	CcSEcCtD
Nelfinavir—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000109	0.00063	CcSEcCtD
Nelfinavir—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000628	CcSEcCtD
Nelfinavir—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000628	CcSEcCtD
Nelfinavir—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000628	CcSEcCtD
Nelfinavir—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000627	CcSEcCtD
Nelfinavir—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000108	0.000627	CcSEcCtD
Nelfinavir—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000108	0.000627	CcSEcCtD
Nelfinavir—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000625	CcSEcCtD
Nelfinavir—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000625	CcSEcCtD
Nelfinavir—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000107	0.000622	CcSEcCtD
Nelfinavir—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000107	0.000621	CcSEcCtD
Nelfinavir—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000621	CcSEcCtD
Nelfinavir—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000618	CcSEcCtD
Nelfinavir—Rash—Vincristine—peripheral nervous system neoplasm	0.000106	0.000617	CcSEcCtD
Nelfinavir—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000106	0.000616	CcSEcCtD
Nelfinavir—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000614	CcSEcCtD
Nelfinavir—Headache—Vincristine—peripheral nervous system neoplasm	0.000106	0.000613	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.00061	CcSEcCtD
Nelfinavir—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000608	CcSEcCtD
Nelfinavir—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000605	CcSEcCtD
Nelfinavir—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000104	0.000603	CcSEcCtD
Nelfinavir—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000102	0.000592	CcSEcCtD
Nelfinavir—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000591	CcSEcCtD
Nelfinavir—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000584	CcSEcCtD
Nelfinavir—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000101	0.000584	CcSEcCtD
Nelfinavir—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000582	CcSEcCtD
Nelfinavir—Nausea—Vincristine—peripheral nervous system neoplasm	0.0001	0.000581	CcSEcCtD
Nelfinavir—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.00058	CcSEcCtD
Nelfinavir—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	9.98e-05	0.000579	CcSEcCtD
Nelfinavir—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	9.98e-05	0.000579	CcSEcCtD
Nelfinavir—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	9.91e-05	0.000574	CcSEcCtD
Nelfinavir—Asthenia—Etoposide—peripheral nervous system neoplasm	9.81e-05	0.000569	CcSEcCtD
Nelfinavir—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	9.81e-05	0.000569	CcSEcCtD
Nelfinavir—Angiopathy—Epirubicin—peripheral nervous system neoplasm	9.79e-05	0.000567	CcSEcCtD
Nelfinavir—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	9.74e-05	0.000565	CcSEcCtD
Nelfinavir—Pruritus—Etoposide—peripheral nervous system neoplasm	9.67e-05	0.000561	CcSEcCtD
Nelfinavir—Vomiting—Cisplatin—peripheral nervous system neoplasm	9.49e-05	0.00055	CcSEcCtD
Nelfinavir—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	9.44e-05	0.000547	CcSEcCtD
Nelfinavir—Rash—Cisplatin—peripheral nervous system neoplasm	9.41e-05	0.000545	CcSEcCtD
Nelfinavir—Dermatitis—Cisplatin—peripheral nervous system neoplasm	9.4e-05	0.000545	CcSEcCtD
Nelfinavir—Malnutrition—Epirubicin—peripheral nervous system neoplasm	9.39e-05	0.000544	CcSEcCtD
Nelfinavir—Erythema—Epirubicin—peripheral nervous system neoplasm	9.39e-05	0.000544	CcSEcCtD
Nelfinavir—Diarrhoea—Etoposide—peripheral nervous system neoplasm	9.36e-05	0.000542	CcSEcCtD
Nelfinavir—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	9.33e-05	0.000541	CcSEcCtD
Nelfinavir—Flatulence—Epirubicin—peripheral nervous system neoplasm	9.25e-05	0.000536	CcSEcCtD
Nelfinavir—Back pain—Epirubicin—peripheral nervous system neoplasm	9.08e-05	0.000527	CcSEcCtD
Nelfinavir—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	9.06e-05	0.000525	CcSEcCtD
Nelfinavir—Dizziness—Etoposide—peripheral nervous system neoplasm	9.04e-05	0.000524	CcSEcCtD
Nelfinavir—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	9.03e-05	0.000523	CcSEcCtD
Nelfinavir—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	9.02e-05	0.000523	CcSEcCtD
Nelfinavir—Nausea—Cisplatin—peripheral nervous system neoplasm	8.87e-05	0.000514	CcSEcCtD
Nelfinavir—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	8.71e-05	0.000505	CcSEcCtD
Nelfinavir—Vomiting—Etoposide—peripheral nervous system neoplasm	8.69e-05	0.000504	CcSEcCtD
Nelfinavir—Erythema—Doxorubicin—peripheral nervous system neoplasm	8.69e-05	0.000504	CcSEcCtD
Nelfinavir—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	8.69e-05	0.000504	CcSEcCtD
Nelfinavir—Anaemia—Epirubicin—peripheral nervous system neoplasm	8.68e-05	0.000503	CcSEcCtD
Nelfinavir—Agitation—Epirubicin—peripheral nervous system neoplasm	8.63e-05	0.0005	CcSEcCtD
Nelfinavir—Rash—Etoposide—peripheral nervous system neoplasm	8.62e-05	0.0005	CcSEcCtD
Nelfinavir—Dermatitis—Etoposide—peripheral nervous system neoplasm	8.61e-05	0.000499	CcSEcCtD
Nelfinavir—Headache—Etoposide—peripheral nervous system neoplasm	8.57e-05	0.000496	CcSEcCtD
Nelfinavir—Flatulence—Doxorubicin—peripheral nervous system neoplasm	8.56e-05	0.000496	CcSEcCtD
Nelfinavir—Malaise—Epirubicin—peripheral nervous system neoplasm	8.47e-05	0.000491	CcSEcCtD
Nelfinavir—Leukopenia—Epirubicin—peripheral nervous system neoplasm	8.41e-05	0.000487	CcSEcCtD
Nelfinavir—Back pain—Doxorubicin—peripheral nervous system neoplasm	8.41e-05	0.000487	CcSEcCtD
Nelfinavir—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	8.35e-05	0.000484	CcSEcCtD
Nelfinavir—Convulsion—Epirubicin—peripheral nervous system neoplasm	8.14e-05	0.000472	CcSEcCtD
Nelfinavir—Nausea—Etoposide—peripheral nervous system neoplasm	8.12e-05	0.000471	CcSEcCtD
Nelfinavir—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	8.06e-05	0.000467	CcSEcCtD
Nelfinavir—Anaemia—Doxorubicin—peripheral nervous system neoplasm	8.03e-05	0.000466	CcSEcCtD
Nelfinavir—Arthralgia—Epirubicin—peripheral nervous system neoplasm	8e-05	0.000463	CcSEcCtD
Nelfinavir—Myalgia—Epirubicin—peripheral nervous system neoplasm	8e-05	0.000463	CcSEcCtD
Nelfinavir—Agitation—Doxorubicin—peripheral nervous system neoplasm	7.99e-05	0.000463	CcSEcCtD
Nelfinavir—Anxiety—Epirubicin—peripheral nervous system neoplasm	7.97e-05	0.000462	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	7.94e-05	0.00046	CcSEcCtD
Nelfinavir—Discomfort—Epirubicin—peripheral nervous system neoplasm	7.9e-05	0.000458	CcSEcCtD
Nelfinavir—Malaise—Doxorubicin—peripheral nervous system neoplasm	7.84e-05	0.000454	CcSEcCtD
Nelfinavir—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	7.78e-05	0.000451	CcSEcCtD
Nelfinavir—Oedema—Epirubicin—peripheral nervous system neoplasm	7.66e-05	0.000444	CcSEcCtD
Nelfinavir—Convulsion—Doxorubicin—peripheral nervous system neoplasm	7.53e-05	0.000436	CcSEcCtD
Nelfinavir—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	7.5e-05	0.000435	CcSEcCtD
Nelfinavir—Skin disorder—Epirubicin—peripheral nervous system neoplasm	7.45e-05	0.000432	CcSEcCtD
Nelfinavir—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	7.41e-05	0.000429	CcSEcCtD
Nelfinavir—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	7.4e-05	0.000429	CcSEcCtD
Nelfinavir—Myalgia—Doxorubicin—peripheral nervous system neoplasm	7.4e-05	0.000429	CcSEcCtD
Nelfinavir—Anxiety—Doxorubicin—peripheral nervous system neoplasm	7.37e-05	0.000427	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	7.35e-05	0.000426	CcSEcCtD
Nelfinavir—Discomfort—Doxorubicin—peripheral nervous system neoplasm	7.31e-05	0.000424	CcSEcCtD
Nelfinavir—Anorexia—Epirubicin—peripheral nervous system neoplasm	7.31e-05	0.000423	CcSEcCtD
Nelfinavir—Oedema—Doxorubicin—peripheral nervous system neoplasm	7.09e-05	0.000411	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	6.98e-05	0.000405	CcSEcCtD
Nelfinavir—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	6.94e-05	0.000402	CcSEcCtD
Nelfinavir—Insomnia—Epirubicin—peripheral nervous system neoplasm	6.93e-05	0.000402	CcSEcCtD
Nelfinavir—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	6.89e-05	0.000399	CcSEcCtD
Nelfinavir—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	6.88e-05	0.000399	CcSEcCtD
Nelfinavir—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	6.86e-05	0.000397	CcSEcCtD
Nelfinavir—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	6.83e-05	0.000396	CcSEcCtD
Nelfinavir—Somnolence—Epirubicin—peripheral nervous system neoplasm	6.81e-05	0.000395	CcSEcCtD
Nelfinavir—Anorexia—Doxorubicin—peripheral nervous system neoplasm	6.76e-05	0.000392	CcSEcCtD
Nelfinavir—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	6.75e-05	0.000391	CcSEcCtD
Nelfinavir—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	6.66e-05	0.000386	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	6.62e-05	0.000384	CcSEcCtD
Nelfinavir—Pain—Epirubicin—peripheral nervous system neoplasm	6.55e-05	0.00038	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	6.46e-05	0.000375	CcSEcCtD
Nelfinavir—Insomnia—Doxorubicin—peripheral nervous system neoplasm	6.41e-05	0.000372	CcSEcCtD
Nelfinavir—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	6.37e-05	0.000369	CcSEcCtD
Nelfinavir—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	6.32e-05	0.000366	CcSEcCtD
Nelfinavir—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	6.32e-05	0.000366	CcSEcCtD
Nelfinavir—Somnolence—Doxorubicin—peripheral nervous system neoplasm	6.3e-05	0.000365	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	6.27e-05	0.000363	CcSEcCtD
Nelfinavir—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	6.24e-05	0.000362	CcSEcCtD
Nelfinavir—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	6.17e-05	0.000357	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	6.12e-05	0.000355	CcSEcCtD
Nelfinavir—Urticaria—Epirubicin—peripheral nervous system neoplasm	6.09e-05	0.000353	CcSEcCtD
Nelfinavir—Pain—Doxorubicin—peripheral nervous system neoplasm	6.06e-05	0.000352	CcSEcCtD
Nelfinavir—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	6.06e-05	0.000351	CcSEcCtD
Nelfinavir—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	6.06e-05	0.000351	CcSEcCtD
Nelfinavir—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	5.84e-05	0.000339	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	5.8e-05	0.000336	CcSEcCtD
Nelfinavir—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	5.65e-05	0.000327	CcSEcCtD
Nelfinavir—Urticaria—Doxorubicin—peripheral nervous system neoplasm	5.63e-05	0.000327	CcSEcCtD
Nelfinavir—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	5.61e-05	0.000325	CcSEcCtD
Nelfinavir—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	5.61e-05	0.000325	CcSEcCtD
Nelfinavir—Asthenia—Epirubicin—peripheral nervous system neoplasm	5.5e-05	0.000319	CcSEcCtD
Nelfinavir—Pruritus—Epirubicin—peripheral nervous system neoplasm	5.42e-05	0.000314	CcSEcCtD
Nelfinavir—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	5.24e-05	0.000304	CcSEcCtD
Nelfinavir—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	5.23e-05	0.000303	CcSEcCtD
Nelfinavir—Asthenia—Doxorubicin—peripheral nervous system neoplasm	5.09e-05	0.000295	CcSEcCtD
Nelfinavir—Dizziness—Epirubicin—peripheral nervous system neoplasm	5.07e-05	0.000294	CcSEcCtD
Nelfinavir—Pruritus—Doxorubicin—peripheral nervous system neoplasm	5.02e-05	0.000291	CcSEcCtD
Nelfinavir—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.87e-05	0.000282	CcSEcCtD
Nelfinavir—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.000281	CcSEcCtD
Nelfinavir—Rash—Epirubicin—peripheral nervous system neoplasm	4.83e-05	0.00028	CcSEcCtD
Nelfinavir—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.83e-05	0.00028	CcSEcCtD
Nelfinavir—Headache—Epirubicin—peripheral nervous system neoplasm	4.8e-05	0.000278	CcSEcCtD
Nelfinavir—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.69e-05	0.000272	CcSEcCtD
Nelfinavir—Nausea—Epirubicin—peripheral nervous system neoplasm	4.55e-05	0.000264	CcSEcCtD
Nelfinavir—Vomiting—Doxorubicin—peripheral nervous system neoplasm	4.51e-05	0.000261	CcSEcCtD
Nelfinavir—Rash—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000259	CcSEcCtD
Nelfinavir—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000259	CcSEcCtD
Nelfinavir—Headache—Doxorubicin—peripheral nervous system neoplasm	4.44e-05	0.000258	CcSEcCtD
Nelfinavir—Nausea—Doxorubicin—peripheral nervous system neoplasm	4.21e-05	0.000244	CcSEcCtD
